Metabolic Disorders
GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Metabolic Disorders market. Reports cover market growth forecasts, trends and research, and more.
Browse our full list of Metabolic Disorders market reports here.
- Currency Conversion is for Indicative purpose only. All orders are processed in US Dollars only.
- USD - US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
- The Price Conversion is only for the Indicative purpose.
- USD — US Dollar
- AUD — Australian Dollar
- BRL — Brazilian Real
- CNY — Yuan Renminbi
- EUR — Euro
- GBP — Pound Sterling
- INR — Indian Rupee
- JPY — Japanese Yen
- ZAR — South African Rand
-
Product Insights
Hypertriglyceridemia Global Clinical Trials Review, H1, 2016 Hypertriglyceridemia Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Hypertriglyceridemia Global Clinical Trials Review, H1, 2016" provides an overview of Hypertriglyceridemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypertriglyceridemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2016 Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2016" provides an overview of Phenylketonuria (PKU) clinical trials scenario. This report provides top line data relating to the clinical trials on Phenylketonuria (PKU). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ) Global Clinical Trials Review, H1, 2016 Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ) Global Clinical Trials Review, H1, 2016
$2,500 | June 2016 GlobalData's clinical trial report, “Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ) Global Clinical Trials Review, H1, 2016" provides an overview of Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ) clinical trials scenario. This report provides top line data relating to the clinical trials on Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome ). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...
-
Sector Analysis
EpiCast Report: Type 2 Diabetes – Epidemiology Forecast to 2025 EpiCast Report: Type 2 Diabetes – Epidemiology Forecast to 2025
$3,995 | June 2016 Type 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body's inability to make use of available insulin along with relative insulin deficiency. T2D constitutes approximately 90% of all diabetes cases around the world; type 1 diabetes (T1D) and gestational diabetes make up the remaining 10% of the cases. Risk factors for T2D are broadly categorized as either modifiable or non-modifiable risk factors. Lifestyle...
-
Product Insights
Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016 Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016
$2,500 | May 2016 GlobalData's clinical trial report, “Diabetic Foot Infection (DFI) Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Foot Infection (DFI) clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Foot Infection (DFI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016 Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016
$2,500 | May 2016 GlobalData's clinical trial report, “Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Ketoacidosis clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Ketoacidosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Nephropathy Global Clinical Trials Review, H1, 2016 Diabetic Nephropathy Global Clinical Trials Review, H1, 2016
$2,500 | May 2016 GlobalData's clinical trial report, “Diabetic Nephropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Nephropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Neuropathy Global Clinical Trials Review, H1, 2016 Diabetic Neuropathy Global Clinical Trials Review, H1, 2016
$2,500 | May 2016 GlobalData's clinical trial report, “Diabetic Neuropathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Neuropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Neuropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetic Retinopathy Global Clinical Trials Review, H1, 2016 Diabetic Retinopathy Global Clinical Trials Review, H1, 2016
$2,500 | May 2016 GlobalData's clinical trial report, “Diabetic Retinopathy Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Retinopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Retinopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Diabetes Insipidus Global Clinical Trials Review, H1, 2016 Diabetes Insipidus Global Clinical Trials Review, H1, 2016
$2,500 | May 2016 GlobalData's clinical trial report, “Diabetes Insipidus Global Clinical Trials Review, H1, 2016" provides an overview of Diabetes Insipidus clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetes Insipidus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.